Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qnostics is a UK-based molecular diagnostics quality control company focused on infectious disease testing. The company develops, manufactures, and supplies molecular quality control materials, evaluation panels, and analytical services used by clinical laboratories, IVD assay developers, external quality assessment providers, pharmaceutical companies, and CROs. Its product portfolio centers on characterized viral, bacterial, and fungal controls that support nucleic acid testing and other molecular infectious disease workflows. Qnostics appears to operate as a commercial diagnostics tools and quality-control supplier rather than a therapeutic drug developer, so it does not have a traditional drug pipeline or clinical-stage asset base. The company is headquartered in Glasgow, Scotland and has operated since 2003.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qnostics.